Skip to main content
Erschienen in: Neurological Sciences 12/2014

01.12.2014 | Original Article

Decreased antioxidant status in migraine patients with brain white matter hyperintensities

verfasst von: Bilal Aytaç, Özlem Coşkun, Bülent Alioğlu, Zahide Esra Durak, Süleyman Büber, Esra Tapçi, Ruhşen Öcal, Levent Ertuğrul İnan, İlker Durak, Tahir Kurtuluş Yoldaş

Erschienen in: Neurological Sciences | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Migraine patients have an increased risk to develop deep white matter hyperintensities (WMH) than the general population. Oxidative stress is believed to play a role in the pathogenesis of migraine. The present study was undertaken to assess oxidant/antioxidant balance of migraineurs with and without WMH. We hypothesized that increased oxidative stress and decreased antioxidant response may play a role in the pathophysiology of WMH in migraineurs. The study included 32 patients in the migraine group and 17 age- and sex-matched healthy subjects without headache in the control group. The migraine group comprised 18 with WMH and 14 without WMH. We evaluated oxidative status with malondialdehyde (MDA) and to determine the activities of antioxidant enzymes: superoxide dismutase, glutathione peroxidase and catalase (CAT) in serum of migraineurs and controls. Comparison of the patient and control groups for oxidative parameters revealed significantly lower level of CAT and higher level of MDA in the patient group. Two-way comparison for CAT and MDA of the migraine with and without WMH and the controls revealed that CAT serum level significantly decreased in migraine patients with WMH than migraine patients without WMH and controls. In this preliminary study, we demonstrated that the levels of CAT were decreased in migraine patients with WMH compared to patients without WMH and controls. These findings suggest that decreased antioxidant response may play a role in the pathophysiology of WMH in migraineurs. Besides, our results encourage the new treatment and follow-up options based on antioxidant systems.
Literatur
1.
Zurück zum Zitat Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(Suppl 1):9–160 Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(Suppl 1):9–160
2.
Zurück zum Zitat Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291(4):427–434PubMedCrossRef Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291(4):427–434PubMedCrossRef
3.
Zurück zum Zitat Aradi M, Schwarcz A, Perlaki G, Orsi G, Kovacs N, Trauninger A et al (2013) Quantitative MRI studies of chronic brain white matter hyperintensities in migraine patients. Headache 53(5):752–763PubMedCrossRef Aradi M, Schwarcz A, Perlaki G, Orsi G, Kovacs N, Trauninger A et al (2013) Quantitative MRI studies of chronic brain white matter hyperintensities in migraine patients. Headache 53(5):752–763PubMedCrossRef
4.
Zurück zum Zitat Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(Suppl 2):S107–S110PubMedCrossRef Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(Suppl 2):S107–S110PubMedCrossRef
5.
Zurück zum Zitat Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME (2006) Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26(4):361–372PubMedCrossRef Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME (2006) Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26(4):361–372PubMedCrossRef
6.
Zurück zum Zitat Tajti J, Pardutz A, Vamos E, Tuka B, Kuris A, Bohar Z et al (2011) Migraine is a neuronal disease. J Neural Transm 118(4):511–524PubMedCrossRef Tajti J, Pardutz A, Vamos E, Tuka B, Kuris A, Bohar Z et al (2011) Migraine is a neuronal disease. J Neural Transm 118(4):511–524PubMedCrossRef
7.
Zurück zum Zitat Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161(2):327–341PubMedCrossRef Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161(2):327–341PubMedCrossRef
8.
Zurück zum Zitat Gupta R, Bhatia MS, Banerjee B (2010) Oxidative stress in migraine: mechanisms and response to treatment. Indian J Priv Psychiatry 4(2):30–34 Gupta R, Bhatia MS, Banerjee B (2010) Oxidative stress in migraine: mechanisms and response to treatment. Indian J Priv Psychiatry 4(2):30–34
9.
Zurück zum Zitat Dahle LK, Hill EG, Holman RT (1962) The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 98:53–261CrossRef Dahle LK, Hill EG, Holman RT (1962) The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 98:53–261CrossRef
10.
Zurück zum Zitat Durak I, Canbolat O, Kavutcu M, Ozturk HS, Yurtarslani Z (1996) Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 10(1):17–20PubMedCrossRef Durak I, Canbolat O, Kavutcu M, Ozturk HS, Yurtarslani Z (1996) Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 10(1):17–20PubMedCrossRef
11.
Zurück zum Zitat Aebi H (1974) Catalase. In: Bergmeyer HU (ed) A methods of enzymatic analysis. Academic Press, New York, pp 673–677CrossRef Aebi H (1974) Catalase. In: Bergmeyer HU (ed) A methods of enzymatic analysis. Academic Press, New York, pp 673–677CrossRef
12.
Zurück zum Zitat Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70(1):158–169PubMed Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70(1):158–169PubMed
13.
Zurück zum Zitat Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30(2):129–136PubMedCentralPubMed Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30(2):129–136PubMedCentralPubMed
14.
Zurück zum Zitat Swartz RH, Kern RZ (2004) Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61(9):1366–1368PubMedCrossRef Swartz RH, Kern RZ (2004) Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61(9):1366–1368PubMedCrossRef
15.
Zurück zum Zitat Bolayir E, Celik K, Kugu N, Yilmaz A, Topaktas S, Bakir S (2004) Intraerythrocyte antioxidant enzyme activities in migraine and tension-type headaches. J Chin Med Assoc 67(6):263–267PubMed Bolayir E, Celik K, Kugu N, Yilmaz A, Topaktas S, Bakir S (2004) Intraerythrocyte antioxidant enzyme activities in migraine and tension-type headaches. J Chin Med Assoc 67(6):263–267PubMed
16.
Zurück zum Zitat Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2003) Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 23(1):39–42PubMedCrossRef Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2003) Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 23(1):39–42PubMedCrossRef
17.
Zurück zum Zitat Gupta R, Pathak R, Bhatia MS, Banerjee BD (2009) Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group. Ann Indian Acad Neurol 12(3):167–172PubMedCentralPubMedCrossRef Gupta R, Pathak R, Bhatia MS, Banerjee BD (2009) Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group. Ann Indian Acad Neurol 12(3):167–172PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S (1999) Platelet nitric oxide metabolites in migraine. Cephalalgia 19(4):218–222PubMedCrossRef Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S (1999) Platelet nitric oxide metabolites in migraine. Cephalalgia 19(4):218–222PubMedCrossRef
19.
Zurück zum Zitat Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, Marini C, Ciancarelli I, Carolei A (1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia 17(5):580–584PubMedCrossRef Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, Marini C, Ciancarelli I, Carolei A (1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia 17(5):580–584PubMedCrossRef
20.
Zurück zum Zitat Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbicer H (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126(1–3):92–97PubMedCrossRef Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbicer H (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126(1–3):92–97PubMedCrossRef
21.
Zurück zum Zitat Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D (2007) Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 211(1):23–30PubMedCrossRef Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D (2007) Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 211(1):23–30PubMedCrossRef
22.
Zurück zum Zitat Bockowski L, Sobaniec W, Kulak W, Smigielska-Kuzia J (2008) Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 60(4):542–548PubMed Bockowski L, Sobaniec W, Kulak W, Smigielska-Kuzia J (2008) Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 60(4):542–548PubMed
23.
Zurück zum Zitat Erol I, Alehan F, Aldemir D, Ogus E (2010) Increased vulnerability to oxidative stress in pediatric migraine patients. Pediatr Neurol 43(1):21–24PubMedCrossRef Erol I, Alehan F, Aldemir D, Ogus E (2010) Increased vulnerability to oxidative stress in pediatric migraine patients. Pediatr Neurol 43(1):21–24PubMedCrossRef
24.
Zurück zum Zitat Shukla R, Barthwal MK, Srivastava N, Sharma P, Raghavan SA, Nag D et al (2004) Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 24(1):37–43PubMedCrossRef Shukla R, Barthwal MK, Srivastava N, Sharma P, Raghavan SA, Nag D et al (2004) Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 24(1):37–43PubMedCrossRef
25.
Zurück zum Zitat Seneviratne U, Chong W, Billimoria PH (2013) Brain white matter hyperintensities in migraine: clinical and radiological correlates. Clin Neurol Neurosurg 115(7):1040–1043PubMedCrossRef Seneviratne U, Chong W, Billimoria PH (2013) Brain white matter hyperintensities in migraine: clinical and radiological correlates. Clin Neurol Neurosurg 115(7):1040–1043PubMedCrossRef
26.
Zurück zum Zitat Spitz DR, Adams DT, Sherman CM, Roberts RJ (1992) Mechanisms of cellular resistance to hydrogen peroxide, hyperoxia, and 4-hydroxy-2-nonenal toxicity: the significance of increased catalase activity in H2O2-resistant fibroblasts. Arch Biochem Biophys 292(1):221–227PubMedCrossRef Spitz DR, Adams DT, Sherman CM, Roberts RJ (1992) Mechanisms of cellular resistance to hydrogen peroxide, hyperoxia, and 4-hydroxy-2-nonenal toxicity: the significance of increased catalase activity in H2O2-resistant fibroblasts. Arch Biochem Biophys 292(1):221–227PubMedCrossRef
27.
Zurück zum Zitat Karlidag R, Unal S, Sezer OH, Bay Karabulut A, Battaloglu B, But A et al (2006) The role of oxidative stress in postoperative delirium. Gen Hosp Psychiatry 28(5):418–423PubMedCrossRef Karlidag R, Unal S, Sezer OH, Bay Karabulut A, Battaloglu B, But A et al (2006) The role of oxidative stress in postoperative delirium. Gen Hosp Psychiatry 28(5):418–423PubMedCrossRef
Metadaten
Titel
Decreased antioxidant status in migraine patients with brain white matter hyperintensities
verfasst von
Bilal Aytaç
Özlem Coşkun
Bülent Alioğlu
Zahide Esra Durak
Süleyman Büber
Esra Tapçi
Ruhşen Öcal
Levent Ertuğrul İnan
İlker Durak
Tahir Kurtuluş Yoldaş
Publikationsdatum
01.12.2014
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 12/2014
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1864-8

Weitere Artikel der Ausgabe 12/2014

Neurological Sciences 12/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.